AVAH Stock Forecast & Price Target

Aveanna Healthcare Hldgs is attractive because its core pediatric private duty nursing business serves a protected, medically complex population in a lower-cost home setting, creating durable demand and strong value for Medicaid MCOs and state legislators. Management’s raised long-term organic growth targets, the expectation for double-digit annual revenue growth including M&A, and preferred payor momentum—such as PDS MCO volume mix rising to 64% and HH&H episodic mix at 81%—support a stronger growth and margin outlook. The California Medi-Cal PDN rate increase effective January 1, 2027, plus improving reimbursement visibility and delevering from free cash flow, further strengthen the fundamental case.

Aveanna Healthcare Hldgs is challenged by heavy dependence on government reimbursement, especially in its Private Duty Services business, where Medicaid and Medicaid MCO rates create meaningful exposure to policy and legislative delays. The bearish case also reflects persistent labor headwinds and nurse availability risk in a tight labor market, which could cut FY27 adjusted EBITDA by 10% and pressure valuation to about 8x downside EBITDA. Additional fundamental risks include regulatory and audit issues, high leverage, and M&A execution and integration risk, while stalled preferred payor strategy and slower organic growth could further limit margin recovery and earnings visibility.